G

Genexine Inc
KOSDAQ:095700

Watchlist Manager
Genexine Inc
KOSDAQ:095700
Watchlist
Price: 4 510 KRW -1.31% Market Closed
Market Cap: 205.4B KRW

Genexine Inc
Investor Relations

Genexine, Inc. engages in research and development of therapeutic vaccines hybrid Fc fusion proteins (hyFc) and DNA (deoxyribonucleic acid) therapeutic vaccines. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2009-09-15. The firm operates its business through two segments. The New Drug Development segment engages in human growth hormone, neutropenia treatment, anemia treatment, anticancer immunotherapy, hyFc platform, and other technology transfers. In addition, this segment sells the technical property rights of follicle-stimulating hormone. The company also engages in cell line construction and sample production, project development, animal testing, human growth hormone development, and government agency research. The Medical Consumables segment produces and sells medical consumables such as medicine bags.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Neil K. Warma M.B.A.
President & Director
No Bio Available
Dr. Young-Chul Sung Ph.D.
Founder & Chairman of the Scientific Advisory Board
No Bio Available
Mr. Sung-June Hong CPA
Executive VP, CFO & Director
No Bio Available
Jongsoo Lee
Senior Manager of IR & PR
No Bio Available
Hyun Jin Park
EVP of Corporate Development
No Bio Available
Dr. Jong Sup Park M.D., Ph.D.
Chief Medical Officer
No Bio Available
Jang Hee Lee
EVP of Operations
No Bio Available
Ki Yong Kim
SVP of Bio Research Institute
No Bio Available
Chul Jun Hyun
Auditor & Director
No Bio Available

Contacts

Address
GYEONGGI-DO
Seongnam
4F, B Dong, Korea Bio Park , 700, Daewangpangyo-ro, Bundang-gu
Contacts
+82316283200
genexine.com